DarioHealth Corp.

NASDAQ: DRIO · Real-Time Price · USD
0.43
-0.07 (-14.51%)
At close: Aug 12, 2025, 3:59 PM

DarioHealth Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
28.03M 27.04M 23.05M 19.15M 19.04M 20.35M 23.55M 26.63M 26.66M 27.66M 26.88M 25.9M 24.98M 20.51M 16.57M 12.98M 9.5M
Cost of Revenue
13.32M 13.77M 13.86M 13.22M 13.8M 14.37M 14.96M 16.86M 17.82M 18M 19.4M 19.4M 18.11M 16.55M 12.6M 9.29M 6.69M
Gross Profit
14.72M 13.27M 9.2M 5.93M 5.25M 5.98M 8.58M 9.77M 8.84M 9.65M 7.47M 6.5M 6.87M 3.96M 3.96M 3.69M 2.81M
Operating Income
-49.89M -57.74M -59.45M -62.97M -60.91M -56.06M -50.98M -50.01M -53.35M -56.81M -69.47M -77.39M -78.04M -76.49M -63.89M -48M -34.12M
Interest Income
161K 551K 860K 1.39M 1.92M 1.87M 1.68M 1.34M 811K 480K 210K 12K 12K 17K 9K 9K 9K
Pretax Income
5.59M -17.65M -22.39M -20.1M -23.07M -26.73M -25.12M -57.66M -59.1M -62.19M -71.13M -77.94M -77.68M -76.73M -64.17M -48.28M -34.52M
Net Income
-11.26M -32.51M -34.87M -5.64M -18.86M 726.05K 110K -33.48M -34.93M -63.3M -72.27M -78.02M -77.75M -76.76M -64.17M -48.28M -34.52M
Selling & General & Admin
42.25M 46.71M 46.27M 46.3M 45.16M 41.92M 38.73M 39.81M 43.3M 46.82M 56.75M 63M 64.42M 63.24M 54.53M 42.91M 31.07M
Research & Development
21.64M 24.18M 23.09M 23.31M 21.73M 20.25M 20.83M 19.97M 18.89M 19.65M 20.18M 20.89M 20.49M 17.22M 13.33M 8.77M 5.86M
Other Expenses
68.09M 33.55M -58.61M -34.55M -34.55M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
131.99M 103.27M 9.47M 33.78M 31.05M 62.05M 59.57M 59.78M 62.18M 66.47M 76.94M 83.89M 84.91M 80.46M 67.86M 51.68M 36.93M
Interest Expense
22K 942K 1.48M 1.5M 1.52M 1.72M 2.09M 2.07M 2.05M 957K 50K 50K 50K 67K 43K 43K 43K
Selling & Marketing Expenses
25.31M 26.35M 25.4M 25.03M 24.36M 23.79M 23.08M 24.29M 27.13M 30.32M 38.63M 41.76M 42.11M 39.71M 32.37M 25.31M 18.27M
Cost & Expenses
145.3M 117.05M 23.32M 47M 44.84M 76.41M 74.53M 76.64M 80.01M 84.47M 96.34M 103.29M 103.02M 97.01M 80.46M 60.97M 43.62M
Income Tax Expense
-10.1M -12.09M -12.18M -13.41M -3.17M -26.41M -26.47M -24.17M -24.17M 1.11M 1.14M 77K 17K -27K -59K -59K n/a
Shares Outstanding (Basic)
67.18M 40.42M 40.42M 39.83M 34.44M 27.19M 28.82M 28.19M 27.57M 25.72M 22.87M 22.43M 19.62M 15.69M 16.47M 15.69M 14.03M
Shares Outstanding (Diluted)
67.18M 40.42M 40.42M 39.83M 34.44M 27.19M 28.82M 28.19M 27.57M 25.72M 22.97M 22.43M 19.62M 15.69M 16.47M 15.69M 14.03M
EPS (Basic)
0.78 0.44 -0.36 -0.13 -0.64 0.01 -0.04 -1.36 -1.57 -2.83 -3.72 -4.35 -4.68 -4.94 -4.79 -4.32 -4.16
EPS (Diluted)
0.78 0.44 -0.36 -0.13 -0.64 0.01 -0.04 -1.36 -1.57 -2.83 -3.72 -4.35 -4.68 -4.94 -4.79 -4.32 -4.16
EBITDA
-43.2M -50.32M -53.12M -57.59M -56.04M -50.71M -48.81M -47.78M -51.13M -54.78M -65.08M -72.74M -73.49M -72.53M -60.8M -46.35M -33.53M
EBIT
-39.89M -57.74M -63.47M -66.98M -64.81M -59.36M -53.68M -52.71M -56.04M -59.55M -69.51M -77.44M -77.83M -76.24M -63.64M -47.74M -34.12M
Depreciation & Amortization
6.1M 7.43M 6.62M 5.82M 5.3M 5.22M 5.14M 5.04M 5M 4.79M 4.33M 4.54M 4.12M 3.53M 2.79M 1.4M 589K